Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 4/2021

01-11-2021

Analysis of changes in the expression pattern of miR-326 and miR-145 during storage of platelet concentrate in blood bank condition and its relationship with some markers of platelet quality

Authors: Mozhgan Norouzi, Seyed Alireza Mesbah-Namin, Mohammad Reza Deyhim

Published in: Journal of Thrombosis and Thrombolysis | Issue 4/2021

Login to get access

Abstract

Platelet concentrates (PC) are affected by biochemical, morphological and functional changes during storage that are named platelet storage lesion (PSL) can decrease the survival and quality of platelets. The potential role and importance of the microRNAs in diagnosis of this process could be remarkable. The aim of this study was to determine miR-145 and miR-326 associated with apoptosis during PC storage. Ten PC prepared by platelet-rich plasma method were selected by simple random sampling in Iranian Blood Transfusion Organization. The expression pattern of miR-326 and miR-145 during PC storage for 7 days was determined by quantitative Real-time RT-PCR, and then the relationship between expression levels of both microRNAs and some PC quality markers was investigated. Glucose concentration, cell viability, platelet count and aggregation during storage showed a significant decrease compared to day zero (P < 0.05). Reduction of these variables showed a direct correlation with a significant decreasing trend in expression level of miR-145 (r = 0.94, 0.98, 0.96 and r = 0.99, P = 0.01). Lactate dehydrogenase activity showed a significant increase during platelet storage compared to day zero (P < 0.05), which was directly correlated with increased expression of miR-326 (r = 0.97, P = 0.01). Changes in the expression pattern of miR-326 and miR-145 along with biochemical markers, all indicate a decrease in platelet quality during 7 days of storage. Due to the significant correlation between the expression changes of miR-326 and miR-145 with PC quality markers, it seems both of these microRNAs can be considered as remarkable markers for early diagnosis of the PC quality during storage.
Appendix
Available only for authorised users
Literature
1.
go back to reference Schulte C, Mayr M (2019) MicroRNAs: a new understanding of platelet physiology and pathology. Thromb Haemost 119(02):191CrossRef Schulte C, Mayr M (2019) MicroRNAs: a new understanding of platelet physiology and pathology. Thromb Haemost 119(02):191CrossRef
3.
go back to reference Shrivastava M (2009) The platelet storage lesion. Transfus Apheres Sci 41(2):105–113CrossRef Shrivastava M (2009) The platelet storage lesion. Transfus Apheres Sci 41(2):105–113CrossRef
4.
go back to reference Hitoshi Ohto KEN (2011) Overview on platelet preservation: better controls over storage lesion. Transfus Apheres Sci 44(3):321–325CrossRef Hitoshi Ohto KEN (2011) Overview on platelet preservation: better controls over storage lesion. Transfus Apheres Sci 44(3):321–325CrossRef
5.
go back to reference Dahiya N, Sarachana T, Vu L, Becker KG, Wood WH, Zhang Y, Atreya CD (2015) Platelet MicroRNAs: an overview. Transfus Med Rev 29(4):215–219CrossRef Dahiya N, Sarachana T, Vu L, Becker KG, Wood WH, Zhang Y, Atreya CD (2015) Platelet MicroRNAs: an overview. Transfus Med Rev 29(4):215–219CrossRef
6.
go back to reference Deyhim MR, Mesbah-Namin SA, Khoshnaghsh F (2020) Protective effect of L-carnitine on platelet apoptosis during storage of platelet concentrate. Transfus Clin Biol 27:139–146CrossRef Deyhim MR, Mesbah-Namin SA, Khoshnaghsh F (2020) Protective effect of L-carnitine on platelet apoptosis during storage of platelet concentrate. Transfus Clin Biol 27:139–146CrossRef
7.
go back to reference Vangas D, Orrenius S, Aguilar-Santelises M (1997) Alreration in Bcl-2/Bax protein levels in platelets form part of an ionomycininduced process that resembles apoptosi. Br J Haematol 99:824–831CrossRef Vangas D, Orrenius S, Aguilar-Santelises M (1997) Alreration in Bcl-2/Bax protein levels in platelets form part of an ionomycininduced process that resembles apoptosi. Br J Haematol 99:824–831CrossRef
8.
go back to reference Mukai N, Nakayama Y, Ishi S, Murakami T, Ogawa S, Kageyama K, Murakami S, Sasada Y, Yoshioka J, Nakajima Y (2019) Cold storage conditions modify microRNA expressions for platelet transfusion. PLoS ONE 14(7):CrossRef Mukai N, Nakayama Y, Ishi S, Murakami T, Ogawa S, Kageyama K, Murakami S, Sasada Y, Yoshioka J, Nakajima Y (2019) Cold storage conditions modify microRNA expressions for platelet transfusion. PLoS ONE 14(7):CrossRef
9.
go back to reference Xia L, Zeng Z, Tang WH (2018) The role of platelet microparticle associated microRNAs in cellular crosstalk. Front Cardiovasc Med 5:29CrossRef Xia L, Zeng Z, Tang WH (2018) The role of platelet microparticle associated microRNAs in cellular crosstalk. Front Cardiovasc Med 5:29CrossRef
11.
go back to reference Raghuwanshi S, Dahariya S, Musvi SS, Gutti U, Kandi R, Undi RB, Sahu I, Gautam DK, Paddibhatla I, Gutti RK (2019) MicroRNA function in megakaryocytes. Platelets 30(7):809–816CrossRef Raghuwanshi S, Dahariya S, Musvi SS, Gutti U, Kandi R, Undi RB, Sahu I, Gautam DK, Paddibhatla I, Gutti RK (2019) MicroRNA function in megakaryocytes. Platelets 30(7):809–816CrossRef
14.
go back to reference Landry P, Provost P (2011) MicroRNAs as modulators of the platelet proteome. Curr Proteom 8(3):193–199CrossRef Landry P, Provost P (2011) MicroRNAs as modulators of the platelet proteome. Curr Proteom 8(3):193–199CrossRef
15.
go back to reference Zhang B, Pan X, Cobb GP, Anderson TA (2007) microRNAs as oncogenes and tumor suppressors. Dev Biol 302(1):1–12CrossRef Zhang B, Pan X, Cobb GP, Anderson TA (2007) microRNAs as oncogenes and tumor suppressors. Dev Biol 302(1):1–12CrossRef
17.
go back to reference Kannan M, Mohan KVK, Kulkarni S, Atreya C (2009) Membrane array–based differential profiling of platelets during storage for 52 miRNAs associated with apoptosis. Transfusion 49(7):1443–1450CrossRef Kannan M, Mohan KVK, Kulkarni S, Atreya C (2009) Membrane array–based differential profiling of platelets during storage for 52 miRNAs associated with apoptosis. Transfusion 49(7):1443–1450CrossRef
18.
go back to reference Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN, Lee T-H, Miano JM, Ivey KN, Srivastava D (2009) miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460(7256):705CrossRef Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN, Lee T-H, Miano JM, Ivey KN, Srivastava D (2009) miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460(7256):705CrossRef
19.
go back to reference Yaghoubi R, Shamsasanjan K, Karimi G, Zadsar M (2017) Evaluation of the quality of platelet components in Azarbaijan Sharghi province: the comparison in the PSL between a blood center and a hospital. Sci J Iran Blood Transfus Organ 14(4):261–271 Yaghoubi R, Shamsasanjan K, Karimi G, Zadsar M (2017) Evaluation of the quality of platelet components in Azarbaijan Sharghi province: the comparison in the PSL between a blood center and a hospital. Sci J Iran Blood Transfus Organ 14(4):261–271
21.
go back to reference Rajabi A, Sharifi Z, Yari F, Deyhim M, Jalili M (2021) The effect of composol medium on miR-16 expression during platelet storage up to day 7 at room temperature. Cell J 22(4):542–547PubMed Rajabi A, Sharifi Z, Yari F, Deyhim M, Jalili M (2021) The effect of composol medium on miR-16 expression during platelet storage up to day 7 at room temperature. Cell J 22(4):542–547PubMed
22.
go back to reference Deyhim MR, Mesbah-Namin SA, Yari F, Taghikhani M, Amirizadeh N (2015) L-carnitine effectively improves the metabolism and quality of platelet concentrates during storage. Ann Hematol 94(4):671–680CrossRef Deyhim MR, Mesbah-Namin SA, Yari F, Taghikhani M, Amirizadeh N (2015) L-carnitine effectively improves the metabolism and quality of platelet concentrates during storage. Ann Hematol 94(4):671–680CrossRef
23.
go back to reference Sweeney JD, Arduini A (2004) L-carnitine and its possible role in red cell and platelet storage. Transfus Med Rev 18(1):58–65CrossRef Sweeney JD, Arduini A (2004) L-carnitine and its possible role in red cell and platelet storage. Transfus Med Rev 18(1):58–65CrossRef
24.
go back to reference Cesar J, DiMinno G, Alam I, Silver M, Murphy S (1987) Plasma free fatty acid metabolism during storage of platelet concentrates for transfusion. Transfusion 27(5):434–437CrossRef Cesar J, DiMinno G, Alam I, Silver M, Murphy S (1987) Plasma free fatty acid metabolism during storage of platelet concentrates for transfusion. Transfusion 27(5):434–437CrossRef
26.
go back to reference Zhou F, Yang Y, Xing D (2011) Bcl-2 and Bcl-xL play important roles in the crosstalk between autophagy and apoptosis. FEBS J 278(3):403–413CrossRef Zhou F, Yang Y, Xing D (2011) Bcl-2 and Bcl-xL play important roles in the crosstalk between autophagy and apoptosis. FEBS J 278(3):403–413CrossRef
Metadata
Title
Analysis of changes in the expression pattern of miR-326 and miR-145 during storage of platelet concentrate in blood bank condition and its relationship with some markers of platelet quality
Authors
Mozhgan Norouzi
Seyed Alireza Mesbah-Namin
Mohammad Reza Deyhim
Publication date
01-11-2021
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 4/2021
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-021-02467-7

Other articles of this Issue 4/2021

Journal of Thrombosis and Thrombolysis 4/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine